Air Products (APD) has a good chance of returning to a 52-week high. The firm posted revenue of $2.99 billion (-1.3% Y/Y). For the full year of 2024, it will earn up to $12.50, up by 6% - 9% Y/Y).
APD stock is an attractive holding. Management delivered an EPS growth of nearly 10% annually for the last decade. Last quarter, it shared a plan to achieve 10% in annual EPS growth.
In the biotech sector, Moderna (MRNA) is a bottom performer. The stock lost 21% on Thursday after slashing its Covid vaccine outlook. This suggests that Novavax (NVAX), BionTech (BNTX), and Pfizer (PFE) are unattractive holdings on a bet that vaccine sales would recover.
In the semiconductor sector, Arm Holdings (ARM) lost 15.7% yesterday. Weak Q1 results scared its shareholders away. Markets misjudged the revenue potential of AI in the PC, data centers, and smartphones. Unfortunately, the smartphone sector is growing too slowly.
MGM Resorts (MGM) is another under-performing stock. The stock peaked at nearly $47 on July 16 but closed at $37.29. The firm reported revenue growing by 9.6% Y/Y to $4.32 billion. Markets are not reacting positively to the better-than-expected results.
MGM is an attractive holding. It offset the softness in entertainment and food with higher room rates. The visitor count is higher than last year.
Related Stories
